Neurodegenerative diseases and Withania somnifera (L.): An update
- PMID: 32240781
- DOI: 10.1016/j.jep.2020.112769
Neurodegenerative diseases and Withania somnifera (L.): An update
Abstract
Ethnopharmacological relevance: Withania somnifera (L.) Dunal also known as 'Ashwaghanda' in Sanskrit and as 'Indian Winter Cherry' in english. is an important medicinal herb in India. It is widely used in Indian systems of medicine as an adaptogen, nerve tonic, anti-stress, memory enhancer and against cognitive deficits, insomnia, anxiety, infectious diseases, infertility, rheumatoid arthritis and gout over thousands of years. Its formulations are mainly used in Unani and Ayurvedic system of medicine. It is a remarkable centuries old herbal Rasayana used to treat neuronal ailments and is known as ''Sattvic Kapha Rasayana.
Aim of the study: To review neuroprotective properties of Withania somnifera (L.)extract as well as its active constituents in neurodegenerative diseases and other neurological ailments.
Materials and methods: The sources of information used in present article include Indian system of Medicine reports on the use of natural products, Medicinal books, research articles and scientific databases like PubMed, Google Scholar, Web of Science, Science-Direct, SciFinder, ACS Publications and Wiley Online Library.
Results: Research reports based largely on preclinical studies as well as few clinical trials have highlighted the neuroprotective role of Ashwagandha against many neurodegenerative diseases including Alzheimer's, Huntington's and Parkinson's disease. The protective effects of Ashwagandha were accomplished by restoring mitochondrial and endothelial function, mitigation of apoptosis, inflammation and oxidative stress mechanisms.
Conclusion: In this review, we recapitulated neuroprotective properties of Ashwagandha extracts and/or its major constituents and discussed their mechanisms of action and potential therapeutic applications. The pre-clinical as well as clinical studies suggest the use of Withania somnifera (L.) against neurodegenerative disease. However, extensive studies are warranted to validate the use of extract or its single constituents for its clinical use.
Keywords: Alzheimer's disease; Anti-inflammatory; Anti-stress; Huntington's; Nerve tonic; Neuroprotection; Parkinson's disease; Stroke; Withania somnifera; Withanolide-A; Withanone.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest Authors do not have any conflict of interest
Similar articles
-
Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.J Ethnopharmacol. 2021 Jan 10;264:113157. doi: 10.1016/j.jep.2020.113157. Epub 2020 Aug 9. J Ethnopharmacol. 2021. PMID: 32783987 Review.
-
Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.Cent Nerv Syst Agents Med Chem. 2010 Sep 1;10(3):238-46. doi: 10.2174/1871524911006030238. Cent Nerv Syst Agents Med Chem. 2010. PMID: 20528765 Review.
-
Therapeutic Evaluation of Unani Medicine, Including Single Drugs and Polyherbal Formulations with Special Reference to Neurodegenerative Disorders.Altern Ther Health Med. 2024 Sep;30(9):54-64. Altern Ther Health Med. 2024. PMID: 39212516 Review.
-
Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.J Ethnopharmacol. 2021 Apr 24;270:113704. doi: 10.1016/j.jep.2020.113704. Epub 2020 Dec 25. J Ethnopharmacol. 2021. PMID: 33359918 Review.
-
In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.Phytother Res. 2010 Oct;24(10):1567-74. doi: 10.1002/ptr.3261. Phytother Res. 2010. PMID: 20680931
Cited by
-
In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer's disease.Sci Rep. 2024 Nov 13;14(1):27908. doi: 10.1038/s41598-024-78975-2. Sci Rep. 2024. PMID: 39537738 Free PMC article.
-
Effectiveness of Medhasagar Rasa® in Combating Aging-Associated Mild Neurocognitive Disorder: An Open-Label, Exploratory, Interventional Clinical Trial.Cureus. 2024 Sep 16;16(9):e69561. doi: 10.7759/cureus.69561. eCollection 2024 Sep. Cureus. 2024. PMID: 39421129 Free PMC article.
-
The benefits of ashwagandha (Withania somnifera) supplements on brain function and sports performance.Front Nutr. 2024 Aug 2;11:1439294. doi: 10.3389/fnut.2024.1439294. eCollection 2024. Front Nutr. 2024. PMID: 39155932 Free PMC article. Review.
-
Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood.Nutrients. 2024 Jun 8;16(12):1813. doi: 10.3390/nu16121813. Nutrients. 2024. PMID: 38931168 Free PMC article. Clinical Trial.
-
Optimization of Parkinson's disease therapy with plant extracts and nutrition's evolving roles.IBRO Neurosci Rep. 2024 May 24;17:1-12. doi: 10.1016/j.ibneur.2024.05.011. eCollection 2024 Dec. IBRO Neurosci Rep. 2024. PMID: 38872839 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
